Business Wire

ABO - Óskare Capital: Partnership Announcement

Share

Alpha Blue Ocean (ABO) and Óskare Capital are announcing today the formation of a strategic partnership to collaborate on investment opportunities associated with cannabis plant-based medicines as well as synthetic molecules that target the mammalian Endocannabinoid system (ECS). Both companies recognize that there are also investment opportunities related to products, infrastructure technologies and services which will be part of the associated ecosystem for this sector. With a strong focus in Europe, the teams will work together to identify those companies with the greatest potential to enter global markets. This sector is nascent in Europe and is still in early stages of development on the pharmaceutical side; both companies see this as a “blue ocean” opportunity as the market emerges in the years to come.

The partnership is based on biotech, agtech, and life science expertise; track records in the European VC; and strong access to deal flow, all of which will enable the partnership to identify leading assets that will define and shape the market of tomorrow. The companies have the internal expertise to vet “picks and shovels” opportunities that address market needs and create fundamental agtech solutions, candidate formulations and molecules for the pharma and wellness industries. ABO will bring strong dealmaking and public market experience that will complement Óskare’s approach.

Both companies believe this is the critical moment for the sector in Europe, where there are high quality research teams and small companies ready for next level investment and development. Furthermore, because of favorable valuations there are readily available opportunities for ABO and Óskare to invest in and scale.

Part of ABO’s existing activities are in healthcare and focus on medical innovation. With their experience in financing medical trials, ABO are a natural partner for Óskare Capital who’s medical and deeptech led science-first venture capital team knows how to build and scale platforms to disrupt the market. Óskare Capital has a highly specialized thesis, providing significant ground for collaboration in this extremely fast-growing new industrial sector, strengthened by the fact that many of the best companies in the sector operate platform technologies that span multiple verticals. These companies in particular will benefit from having both specialist and generalist expertise to hand.

Óskare Capital’s Chairman, Bruce Linton notes: “Óskare Capital is delighted to be joining forces with ABO. This partnership will help facilitate the realisation of Óskare's vision by the opportunity to work together on deal flow and financing investment opportunities. Together, we will be in a stronger position to influence the development of companies and research teams here in Europe and extend their influence globally.”

Bruce Linton brings significant international experience as he is also the founder of multibillion dollar cannabis company Canopy Growth Corp. (TSX: WEED, Nasdaq: CGC) and a board member for global psychedelic-themed pharma Mind Medicine Inc. (NEO: MMED, Nasdaq: MNMD, DE: MMQ) among other ventures such as Canopy River (now RIV Capital, RIV: CN, CNPOF: US), Red Light Holland (CSE: TRIP, OTC: TRUFF), Gage Growth Corp (CSE: GAGE), Martello Technologies (TSX: MTLO), Creso Pharma (ASX: CPH), Slang (CSE: SLNG) and Innoviz (Nasdaq: INVZ).

Alpha Blue Ocean co-founder, Chairman and CIO, Pierre Vannineuse, comments: “Alpha Blue Ocean, with its expertise in structured product financings, is a recognized leader in financing cannabis companies towards listing and post-listing on stock exchanges. These structures span all asset classes and guarantee the funding needs of our portfolio companies while achieving positive risk adjusted returns. Óskare surrounded themselves with a stellar team whose experience spans all sectors of this new multibillion dollar industry. Some of the biggest fortunes were made after prohibition events and we believe this is the best opportunity to be part of this societal change happening across the world. We are excited to partner with Óskare and assist them with structuring and origination of deals as well as co-invest with them.”

About Óskare Capital SAS

Managed by a team based in Paris, London and New York, Óskare Capital, launched Óskare Fund 1, the first ever AIFM and ESG compatible Venture Capital fund with an investment focus on innovative companies and teams in Europe working on novel therapeutics (cannabinoids and other molecules) that target the endocannabinoid system as well as the associated ecosystem that support this fast-growing global market. Óskare Capital also has launched its MEDCAN fund, the first ever EIS and SEIS fund targeting the medical cannabis sector in the UK. Both funds will invest in startups across the entire value chain (from seed to patient) but will not invest in cannabis production or recreational cannabis.

About Alpha Blue Ocean

Created in 2017, Alpha Blue Ocean is a specialist and pioneer in alternative financing in Europe and in the world, notably in the medical innovations sector. In 4 years, the group founded by Pierre Vannineuse has completed more than EU1.5 billion in financial commitments, of which 60% has been in the Health and Innovation segment.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Rajae Elantari - r.elantari@abo.co
+971585397678

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

LambdaTest Launches The Phoenix Project, an Employee Resource Group for Women28.3.2024 16:00:00 CET | Press release

LambdaTest, a leading cloud-based unified testing platform, announced the launch of The Phoenix Project, an Employee Resource Group (ERG) dedicated to supporting and promoting the success of its female employees. “LambdaTest is committed to fostering a diverse, inclusive, and equitable workplace where all employees feel valued and empowered to reach their full potential,” said Chandini Chopra, VP of People and Culture at LambdaTest. “The Phoenix Project is a critical step towards achieving this goal by providing a platform for professional development, networking, and mentorship, especially for our women employees.” The Phoenix Project Aims To: Offer professional development workshops, networking opportunities, and dedicated time off for women to participate in ERG initiatives. Provide mentorship programs connecting senior female employees with mentees. Promote leadership development among women within the company. Create a sense of community for women in the workplace. Leadership and

The reopening of the Yokohama Museum of Art adds another innovative and distinctive venue for events in Yokohama28.3.2024 16:00:00 CET | Press release

After extensive renovations, the iconic Yokohama Museum of Art has reopened its doors to visitors from all over the world. The museum’s reopening paves the way to new and closer collaboration with international events in Yokohama. This extraordinary venue is the ideal setting for a one-of-a-kind gathering, in part, supported by the Yokohama Convention & Visitors Bureau (hereinafter YCVB). The Yokohama Museum of Art Founded in 1989, the Yokohama Museum of Art collects over 14,000 works of art that reflect the many facets of life in Yokohama—past, present, and future. The reopening of the museum coincides with the Yokohama Triennale, an international exhibition featuring contemporary artists whose decentralized exhibits turn the entire metropolis into an art museum. The 8th Yokohama Triennale is being held from March 15 to June 9, 2024, with the Yokohama Museum of Art being a pivotal venue for the exhibition. With the museum firmly back on the map as Yokohama’s leading artistic venue, YC

Eight new sustainability-themed experiences—exclusive to Yokohama—for convention participants28.3.2024 16:00:00 CET | Press release

In a survey conducted by Yokohama Convention & Visitors Bureau (hereinafter YCVB), many convention attendees expressed particular interest in Yokohama’s culture, sightseeing spots, and local cuisine. In response, YCVB has developed eight new Yokohama Tours for event attendees to enjoy during their free time in Yokohama, keeping in line with our ethos of sustainability. Noge Area Bar-Hopping Tour, complete with guide Known affectionately by locals as Yokohama’s kitchen, Noge is a bustling nightlife spot that is home to over 600 izakaya (Japanese-style pubs). A knowledgeable local guide will lead participants to all the hidden gems in Noge, where they can indulge in distinctive, delicious pub-style food and drink. With easy on-foot accessibility, participants can rest assured this fun night out won’t impact their carbon footprint. Soto Zen Tour of Sojiji, head temple of the Soto Zen school As a prominent Zen sect in Japan, Soto Zen provides one of the best Zen wellness experiences. Durin

Nordson EFD Releases New 3-Axis Automated Fluid Dispensing Systems28.3.2024 15:00:00 CET | Press release

Nordson EFD, a Nordson company (NASDAQ: NDSN) and leading precision fluid dispensing systems manufacturer is proud to announce the new GVPlus and PROX families of automated fluid dispensing products. Both robotic solutions share a focus on motion, workspace, repeatability, payload, setup, and vision technology enhancements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240305726899/en/ The GV Series offers market-leading dimensional positional accuracy and deposit placement repeatability. (Photo: Business Wire) The new GVPlus automated fluid dispensing solution offers improved repeatability, bigger payloads with simplified setup requirements, and superior vision capabilities. Repeatability is now best-in-class at 8 μm, improving repeatability to ±0.008 mm. Setting up the robot is easier due to a new dual mounting flange that enables a tool payload of up to 4.5 kg (10 lbs). When paired with the working area of 400 mm x 400 m

Kolmar Korea Wins Case Against Italian Cosmetics Maker Intercos for Suncare Technology Theft28.3.2024 14:00:00 CET | Press release

Kolmar Korea (KRX:161890), a Korean cosmetics ODM (Original Development Manufacturing) company, has announced its victory in a lawsuit against Intercos Korea, the Korean subsidiary of the Italian cosmetics maker, Intercos. Intercos was revealed to have misappropriated and profited from the key technology for suncare (sunscreen) products, originally developed by Kolmar Korea. Kolmar Korea had invested hundreds of billions of KRW in this technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240328015022/en/ Kolmar Korea wins the case against Italian cosmetics maker Intercos for stealing suncare technology (Kolmar Korea R&D Complex) (Photo: Kolmar Korea Holdings) Kolmar Korea took legal action for 'trade secret infringement' against its former employees who have leaked the technology and Intercos Korea, resulting in favorable rulings in both civil and criminal cases. The Korean courts ordered Intercos Korea to pay KRW 200

HiddenA line styled icon from Orion Icon Library.Eye